https://www.selleckchem.com/pr....oducts/lomeguatrib.h
Patient and breast cancer characteristics did not differ significantly between groups. Recurrence occurred in 7.5% patients. GA patients received more opioids and reported higher post-operative pain than PPA. There was no difference in post-operative MPO in GA vs PPA (10.5±6.6 vs 11.5±4.7ngmL , P=.6. Regarding CitH3, there was no difference post-operatively in GA vs PPA (3.6±2.3 vs 4.0±5.9, P=.8. NET expression did not differ before or after anaesthesia and surgery in either group, for either biomarker. Anaesthetic technique did